From start-ups to leading global companies, Greater Fort Lauderdale provides a stimulating and supportive business environment for success in the life sciences.

Eli Lilly

Lilly buys migraine biotech CoLucid, and the drug it outlicensed, for $960M

After phase 3 failures, Lilly signs new Alzheimer’s drug pact with AstraZeneca

Alzheimer's hopes dashed as Lilly gives up on amyloid drug solanezumab

Janssen seeks FDA approval for IL-23 blockbuster hopeful guselkumab